General situation of Sinopharm Holding Henan Co., Ltd.

In the ranking of pharmaceutical sales published by the Pharmaceutical Business Association, both sales revenue and total profit rank first. Most of the group member enterprises have a history of more than 50 years, shouldering the responsibilities entrusted by the state and people for a long time, and undertaking the mission of ensuring public health and safety and people's lives and health. At present, the Group has ten wholly-owned or holding subsidiaries, one H-share listed company controlled by Sinopharm, and four A-share listed companies controlled by Sinopharm, Tiantan Bio, Hyundai Pharmaceutical and Concord Pharmaceutical. In 20 12, the group is expected to achieve annual operating income of16 billion yuan, ranking among the top 500 in the world and becoming a leading domestic and internationally competitive pharmaceutical and health industry group of central enterprises.

Sinopharm Holdings Henan Co., Ltd. is the only subsidiary of China Pharmaceutical Group in Henan, directly under Sinopharm Holdings, the first enterprise in China to obtain the certificate of Internet drug trading service, and the first emerging pharmaceutical circulation enterprise in China to provide centralized distribution service for online drug procurement in response to the government's call, with a registered capital of 57,765,300 yuan. Since its establishment in 2007, the company has held 10 subsidiaries and set up 4 offices with 1206 employees, including 4 licensed pharmacists. By the end of 20 1 1, the company's sales continued to increase substantially, from 87 million yuan in 2007 to nearly 3.4 billion yuan, with a compound growth rate of 136.2 1%, ranking first in the sales of pharmaceutical sales and circulation industry in Henan Province, and making the contribution of profits and taxes to pharmaceutical circulation industry in Henan Province.

Sinopharm Holdings Henan Co., Ltd. is the first new medical e-commerce (B2B mode) company in China, which was reorganized by Sinopharm Holdings and Zhengzhou Jiurui Pharmaceutical Co., Ltd. It is located 50 meters east of Hanghai Road (107 auxiliary road) and Jingnan Fifth Road in Zhengzhou Economic and Technological Development Zone with beautiful environment, with a registered capital of 57,765,300 yuan and more than 400 employees, including 6 licensed pharmacists. (Project background: In 2005, it was initiated by several EMBA students of China Europe International Business School (including: Chairman of Beijing Bobang Jiayuan Pharmaceutical, President of Shenyang Sansheng Pharmaceutical, Marketing Director of Beijing Shuanghe Pharmaceutical, Financial Director of Shenzhen Taitai Pharmaceutical, etc.). ). They are all industry elites with many years of drug management experience and rich theoretical knowledge. )